{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:54:19Z","timestamp":1784652859654,"version":"3.55.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background and objectives<\/jats:title><jats:p>Autoimmune hepatitis (AIH) is characterized by the expansion and accumulation of pathogenic T cells in liver. Although CD6 and its ligand activated leukocyte cell adhesion molecule (ALCAM) are involved in the evolution of multiple inflammatory diseases, their roles in the pathogenesis of AIH remain unknown. Herein, we aimed to investigate ALCAM-CD6 axis in AIH development.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Immunohistochemistry was performed to examine hepatic expression of CD6 and ALCAM. The concentration of serum ALCAM was evaluated by ELISA. The phenotypes of liver infiltrating T cells were determined by flow cytometry. Primary human CD4<jats:sup>+<\/jats:sup>T cells were used for functional studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our data showed that patients with AIH exhibited significantly higher expression of CD6 in the liver as compared to primary biliary cholangitis (PBC), chronic hepatitis B (CHB), non-alcoholic liver disease (NAFLD), and healthy controls (HC). In addition, hepatic CD6 expression was strongly correlated with disease severity of AIH. CD6 was mainly expressed on CD4<jats:sup>+<\/jats:sup>T cells in the liver and intrahepatic CD6<jats:sup>high<\/jats:sup>CD4<jats:sup>+<\/jats:sup>T cells demonstrated stronger proinflammatory response and proliferation features than CD6<jats:sup>low<\/jats:sup>counterparts in both AIH and HC. ALCAM, the ligand of CD6, was highly expressed in the hepatocytes of AIH and serum ALCAM was strongly associated with clinical indices of AIH. Interestingly, close spatial location between CD6<jats:sup>+<\/jats:sup>CD4<jats:sup>+<\/jats:sup>T cells and ALCAM<jats:sup>+<\/jats:sup>hepatocytes was observed. Finally, we found that CD6<jats:sup>high<\/jats:sup>CD4<jats:sup>+<\/jats:sup>T cells showed enhanced capacity of trans-endothelial migration<jats:italic>in vitro<\/jats:italic>, which could be promoted by recombinant ALCAM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study found that ALCAM-CD6 axis was upregulated in the AIH liver, suggesting a potential target for alleviating AIH.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.967944","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T05:21:38Z","timestamp":1662700898000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Intrahepatic activated leukocyte cell adhesion molecule induces CD6highCD4+ T cell infiltration in autoimmune hepatitis"],"prefix":"10.3389","volume":"13","author":[{"given":"Qiwei","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrui","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis\u2013update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"B2","article-title":"Immune phenotype of chronic liver disease","volume":"43","author":"Czaja","year":"1998","journal-title":"Dig Dis Sci"},{"key":"B3","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","article-title":"Recent advances in clinical practice: epidemiology of autoimmune liver diseases","volume":"70","author":"Trivedi","year":"2021","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cgh.2020.05.061","article-title":"Trends in incidence of autoimmune liver diseases and increasing incidence of autoimmune hepatitis","volume":"19","author":"Lamba","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B5","article-title":"Long-term outcomes of autoimmune hepatitis","volume":"14","author":"Gleeson","year":"2019","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"B6","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1111\/1751-2980.12995","article-title":"CD8(+) T cells actively penetrate hepatocytes via the CD44\/p-ERM\/F-actin pathway in autoimmune hepatitis","volume":"22","author":"Liang","year":"2021","journal-title":"J Dig Dis"},{"key":"B8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2020.06.044","article-title":"Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis","volume":"74","author":"Vuerich","year":"2021","journal-title":"J Hepatol"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1002\/hep.25682","article-title":"The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9\/tim-3 pathway","volume":"56","author":"Liberal","year":"2012","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-pathol-020117-043534","article-title":"Cellular and molecular mechanisms of autoimmune hepatitis","volume":"13","author":"Webb","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1900124","article-title":"TNF-producing Th1 cells are selectively expanded in liver infiltrates of patients with autoimmune hepatitis","volume":"203","author":"Bovensiepen","year":"2019","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102671","article-title":"Increased intrahepatic expression of immune checkpoint molecules in autoimmune liver disease","volume":"10","author":"Macek Jilkova","year":"2021","journal-title":"Cells"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20151785","article-title":"CD6 modulates thymocyte selection and peripheral T cell homeostasis","volume":"213","author":"Orta-Mascaro","year":"2016","journal-title":"J Exp Med"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201011","article-title":"The T cell CD6 receptor operates a multitask signalosome with opposite functions in T cell activation","volume":"218","author":"Mori","year":"2021","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202052196","article-title":"ARHGAP45 controls naive T- and b-cell entry into lymph nodes and T-cell progenitor thymus seeding","volume":"22","author":"He","year":"2021","journal-title":"EMBO Rep"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1704008114","article-title":"CD318 is a ligand for CD6","volume":"114","author":"Enyindah-Asonye","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.173.4.2262","article-title":"Relevance of CD6-mediated interactions in T cell activation and proliferation","volume":"173","author":"Gimferrer","year":"2004","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13075-020-02209-9","article-title":"Urinary activated leukocyte cell adhesion molecule as a novel biomarker of lupus nephritis histology","volume":"22","author":"Ding","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1038\/ni1551","article-title":"Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system","volume":"9","author":"Cayrol","year":"2008","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw0475","article-title":"Activated leukocyte cell adhesion molecule regulates b lymphocyte migration across central nervous system barriers","volume":"11","author":"Michel","year":"2019","journal-title":"Sci Transl Med"},{"key":"B21","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1164\/rccm.201703-0532OC","article-title":"Activated leukocyte cell adhesion molecule stimulates the T-cell response in allergic asthma","volume":"197","author":"Kim","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.4168\/aair.2019.11.5.677","article-title":"Activated leukocyte cell adhesion molecule modulates Th2 immune response in atopic dermatitis","volume":"11","author":"Oh","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"B23","article-title":"CD6 as a potential target for treating multiple sclerosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.2217\/imt-2020-0235","article-title":"An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases","volume":"13","author":"Filgueira","year":"2021","journal-title":"Immunotherapy."},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"B26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American gastroenterological association, American association for the study of liver diseases, and American college of gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"B28","article-title":"European Association For The Study Of The L. EASL clinical practice guidelines: Management of chronic hepatitis b virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31739","article-title":"The clinical significance of hepatic CD69(+) CD103(+) CD8(+) resident-memory T cells in autoimmune hepatitis","volume":"74","author":"You","year":"2021","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjy179","article-title":"Critical role of CD6highCD4+ T cells in driving Th1\/Th17 cell immune responses and mucosal inflammation in IBD","volume":"13","author":"Ma","year":"2019","journal-title":"J Crohns Colitis."},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2002-12-3945","article-title":"CXCR3-mediated chemotaxis of human T cells is regulated by a gi- and phospholipase c-dependent pathway and not via activation of MEK\/p44\/p42 MAPK nor Akt\/PI-3 kinase","volume":"102","author":"Smit","year":"2003","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1514152112","article-title":"Leukocyte-specific protein 1 regulates T-cell migration in rheumatoid arthritis","volume":"112","author":"Hwang","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B33","doi-asserted-by":"crossref","DOI":"10.1038\/nprot.2007.296","article-title":"Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester","volume":"2","author":"Quah","year":"2007","journal-title":"Nat Protoc"},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.1038\/s41588-019-0505-9","article-title":"Landscape of stimulation-responsive chromatin across diverse human immune cells","volume":"51","author":"Calderon","year":"2019","journal-title":"Nat Genet"},{"key":"B35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.autrev.2017.12.004","article-title":"Clinical and experimental evidence for targeting CD6 in immune-based disorders","volume":"17","author":"Consuegra-Fernandez","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cytogfr.2021.07.001","article-title":"ALCAM\/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression","volume":"61","author":"Ferragut","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"key":"B37","doi-asserted-by":"crossref","first-page":"24974","DOI":"10.1038\/srep24974","article-title":"Genetic polymorphisms of cell adhesion molecules in behcet\u2019s disease in a Chinese han population","volume":"6","author":"Zheng","year":"2016","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.2174\/1389450117666160201105934","article-title":"The link between CD6 and autoimmunity: Genetic and cellular associations","volume":"17","author":"Kofler","year":"2016","journal-title":"Curr Drug Targets"},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awp289","article-title":"Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis","volume":"132","author":"Brucklacher-Waldert","year":"2009","journal-title":"Brain"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2020-323771","article-title":"The human liver microenvironment shapes the homing and function of CD4(+) T-cell populations","volume":"71","author":"Wiggins","year":"2022","journal-title":"Gut"},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1614336114","article-title":"Dual role of ALCAM in neuroinflammation and blood-brain barrier homeostasis","volume":"114","author":"Lecuyer","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1002\/art.41288","article-title":"Attenuation of murine collagen-induced arthritis by targeting CD6","volume":"72","author":"Li","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.2174\/1389450117666160201114308","article-title":"Therapeutic targeting of CD6 in autoimmune diseases: A review of Cuban clinical studies with the antibodies IOR-T1 and itolizumab","volume":"17","author":"Hernandez","year":"2016","journal-title":"Curr Drug Targets"},{"key":"B44","doi-asserted-by":"crossref","DOI":"10.1080\/14712598.2021.1905794","article-title":"A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of itolizumab in moderate to severe ARDS patients due to COVID-19","volume":"21","author":"Kumar","year":"2021","journal-title":"Expert Opin Biol Ther"},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.1080\/14712598.2020.1798399","article-title":"Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications","volume":"20","author":"Loganathan","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.08.008","article-title":"Modulation of CD4 T cell function via CD6-targeting","volume":"47","author":"Freitas","year":"2019","journal-title":"EBioMedicine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.967944\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T14:57:16Z","timestamp":1676732236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.967944\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2022.967944"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.967944","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,9]]},"article-number":"967944"}}